Get started
Author

Frederik Peissert

Observed name: Peissert, Frederik
ORCID: 0000-0002-1856-8118
Observed ORCID: 0000-0002-1856-8118
OpenAlex ID: A5054202974
Generation and in vivo validation of an IL-12 fusion protein based on a novel anti-human FAP monoclonal antibody
2022 · Lisa Nadal, Frederik Peissert, et al. · Journal for ImmunoTherapy of Cancer · 31
PDF
Generation and in vivo characterization of a novel high-affinity human antibody targeting carcinoembryonic antigen
2023 · Louis Plüss, Frederik Peissert, et al. · mAbs · 11
PDF
Selection of a PD ‐1 blocking antibody from a novel fully human phage display library
2022 · Frederik Peissert, Louis Plüss, et al. · Protein Science · 11
Optimizing the Design and Geometry of T Cell–Engaging Bispecific Antibodies Targeting CEA in Colorectal Cancer
2024 · Abdullah Elsayed, Louis Plüss, et al. · Molecular Cancer Therapeutics · 10
PDF
Generation of a novel fully human non-superagonistic anti-CD28 antibody with efficient and safe T-cell co-stimulation properties
2023 · Abdullah Elsayed, Christian Pellegrino, et al. · mAbs · 9
PDF
Adapting Neutralizing Antibodies to Viral Variants by Structure‐Guided Affinity Maturation Using Phage Display Technology
2023 · Frederik Peissert, Mattia Pedotti, et al. · Global Challenges · 8
PDF
Expression of CD146 and Regenerative Cytokines by Human Placenta-Derived Mesenchymal Stromal Cells upon Expansion in Different GMP-Compliant Media
2021 · Frederik Peissert, Hannah D. E. Graf, et al. · Stem Cells International · 3
PDF
A comparative analysis of tumor markers reveals EDA fibronectin as a promising target in high-grade serous ovarian cancer
2025 · Alessia Piermattei, Roberto De Luca, et al. · Journal of Ovarian Research · 1
PDF
1093 A novel IL12-based immunocytokine targeting fibroblast activation protein (FAP) for the treatment of cancer
2022 · Lisa Nadal, Frederik Peissert, et al. · Journal for ImmunoTherapy of Cancer · 1
PDF
Figure S1 from Optimizing the Design and Geometry of T Cell–Engaging Bispecific Antibodies Targeting CEA in Colorectal Cancer
2026 · Abdullah Elsayed, Louis Plüss, et al.
Movie S2 from Optimizing the Design and Geometry of T Cell–Engaging Bispecific Antibodies Targeting CEA in Colorectal Cancer
2026 · Abdullah Elsayed, Louis Plüss, et al.
Figure S2 from Optimizing the Design and Geometry of T Cell–Engaging Bispecific Antibodies Targeting CEA in Colorectal Cancer
2026 · Abdullah Elsayed, Louis Plüss, et al.
Figure S3 from Optimizing the Design and Geometry of T Cell–Engaging Bispecific Antibodies Targeting CEA in Colorectal Cancer
2026 · Abdullah Elsayed, Louis Plüss, et al.
Movie S4 from Optimizing the Design and Geometry of T Cell–Engaging Bispecific Antibodies Targeting CEA in Colorectal Cancer
2026 · Abdullah Elsayed, Louis Plüss, et al.
Movie S3 from Optimizing the Design and Geometry of T Cell–Engaging Bispecific Antibodies Targeting CEA in Colorectal Cancer
2026 · Abdullah Elsayed, Louis Plüss, et al.
Movie S1 from Optimizing the Design and Geometry of T Cell–Engaging Bispecific Antibodies Targeting CEA in Colorectal Cancer
2026 · Abdullah Elsayed, Louis Plüss, et al.
Figure S4 from Optimizing the Design and Geometry of T Cell–Engaging Bispecific Antibodies Targeting CEA in Colorectal Cancer
2026 · Abdullah Elsayed, Louis Plüss, et al.
Quantitative Mass Spectrometry-Based Biodistribution of Monoclonal Antibodies: An Alternative to Radio-Biodistribution
2026 · Ravazza, Domenico, Plaza, Sheila Dakhel, et al. · ETH Zürich Research Collection
Quantitative Mass Spectrometry‐Based Biodistribution of Monoclonal Antibodies: An Alternative to Radio‐Biodistribution
2026 · Domenico Ravazza, Sheila Dakhel Plaza, et al. · Advanced Science
Figure S1 from Optimizing the Design and Geometry of T Cell–Engaging Bispecific Antibodies Targeting CEA in Colorectal Cancer
2024 · Abdullah Elsayed, Louis Plüss, et al.
Figure S4 from Optimizing the Design and Geometry of T Cell–Engaging Bispecific Antibodies Targeting CEA in Colorectal Cancer
2024 · Abdullah Elsayed, Louis Plüss, et al.
Figure S3 from Optimizing the Design and Geometry of T Cell–Engaging Bispecific Antibodies Targeting CEA in Colorectal Cancer
2024 · Abdullah Elsayed, Louis Plüss, et al.
Data from Optimizing the Design and Geometry of T Cell–Engaging Bispecific Antibodies Targeting CEA in Colorectal Cancer
2024 · Abdullah Elsayed, Louis Plüss, et al.
Movie S3 from Optimizing the Design and Geometry of T Cell–Engaging Bispecific Antibodies Targeting CEA in Colorectal Cancer
2024 · Abdullah Elsayed, Louis Plüss, et al.
Table S1 from Optimizing the Design and Geometry of T Cell–Engaging Bispecific Antibodies Targeting CEA in Colorectal Cancer
2024 · Abdullah Elsayed, Louis Plüss, et al.
Works count: 39
Citation count: 85
H-index: 6
I10-index: 4
Year
Topic
Type